Our research in Neuroscience
Intended for healthcare professionals, scientific audiences and media.
At Bristol Myers Squibb, we are committed to the development of transformational therapeutics for people with neurodegenerative, neuroinflammatory and neuromuscular diseases, with a focus on areas of high unmet need in both common (e.g., Alzheimer’s disease, multiple sclerosis and Parkinson’s disease) and rare diseases (e.g., ALS and Huntington’s disease). Our research focuses on breakthrough science where disease modification is the goal, including potential first- and best-in-class therapies that can prolong patient survival and meaningfully improve patient outcomes.
Multiple Sclerosis
At Bristol Myers Squibb, we are focused on delivering solutions that may help preserve physical and cognitive function in people living with neurological conditions like multiple sclerosis (MS). Building on our experience, we are pursuing pathbreaking science to improve care for those impacted by the disease. By helping restore some of what MS has taken away, we aim to empower people living with MS and their loved ones to take back control of their lives.
Our scientific innovation
Bristol Myers Squibb is focused on delivering scientific innovation with the empathy and urgency needed to advance care for people living with immune-mediated diseases.
As we continuously build and expand our portfolio, our teams work to identify mechanisms that may reset and promote balance in the immune system, with the goal of achieving long-term remission and, ultimately, curative therapies.
Every day, each of us works to improve outcomes for patients fighting serious immune-mediated diseases. We're creative thinkers motivated by the practical application of our work, and innovators unafraid to step into uncharted territory. Together, we're building a better future for each other and the patients who need us most.